Investment Rating - The report maintains a "Buy" recommendation for China Overseas Property (2669.HK) [1][4][8] Core Views - The company achieved a revenue of 14.96 billion HKD in 2025, representing a 6% increase year-on-year. However, the profit attributable to ordinary shareholders decreased by 9.7% to 1.37 billion HKD. The proposed final dividend is 0.10 HKD per share, with a total annual dividend of 0.20 HKD, marking an 11.1% increase [4][7] - The property management service revenue grew by 9.1% to 11.73 billion HKD, while non-residential value-added services increased by 6.1% to 1.94 billion HKD. However, residential value-added services saw a decline of 12% to 1.22 billion HKD due to weakened demand [7][8] - The company expanded its managed area by 35.3 million square meters to 480 million square meters, with a significant increase in third-party and non-residential proportions [7][8] Financial Summary - Revenue projections for the next few years are as follows: 16.00 billion HKD in 2026, 17.03 billion HKD in 2027, and 18.09 billion HKD in 2028, with year-on-year growth rates of 7.0%, 6.4%, and 6.2% respectively [6][11] - Net profit is expected to recover slightly to 1.41 billion HKD in 2026, with further increases to 1.53 billion HKD in 2027 and 1.71 billion HKD in 2028 [6][11] - The company's gross margin is projected to be 15.0% in 2025, declining to 13.9% in 2026, before recovering to 14.0% in 2027 and 14.5% in 2028 [11] Valuation Metrics - The price-to-earnings (P/E) ratio is projected to be 8.5 in 2025, decreasing to 6.8 by 2028, indicating a potentially attractive valuation [6][11] - The price-to-book (P/B) ratio is expected to decline from 2.0 in 2025 to 1.3 in 2028, suggesting improving value for shareholders over time [11]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected investment return exceeding the market benchmark by more than 15% over the next 6-12 months [6]. Core Insights - In 2025, the company reported a revenue of 3.65 billion yuan, a year-on-year decline of 48.3%, and a net profit of 538 million yuan, down 59.3% year-on-year. The adjusted net profit was 523 million yuan, reflecting a 68.8% decrease [1][4]. - The company is undergoing a channel inventory reduction phase, which has led to significant revenue declines across its brands. The revenue breakdown for 2025 shows declines for its brands: Zhenjiu (-57.11%), Lidou (-17.33%), Xiangjiao (-41.64%), and Kaikouxiao (-69.7%) [2]. - The company is actively reducing inventory for its Zhenjiu brand due to weak market demand and has introduced new products to stimulate growth, including high-end offerings [2][3]. Financial Performance - The gross margin for 2025 was 58.5%, slightly down from 2024, with brand-specific margins showing varied performance. Zhenjiu's margin decreased due to lower contributions from high-end products, while Lidou's margin remained relatively stable [3]. - The sales expense ratio increased to 30.63%, up 7.8 percentage points year-on-year, driven by increased marketing efforts. The management expense ratio also rose to 15.5%, reflecting fixed costs amid revenue pressure [3]. - The adjusted net profit margin for 2025 was 14.3%, down 9.4 percentage points year-on-year, indicating the impact of rising expense ratios on profitability [3]. Earnings Forecast and Valuation - The adjusted net profit forecasts for 2026 and 2027 have been revised down to 665 million yuan and 806 million yuan, respectively, representing reductions of 51% and 44% from previous estimates. A new forecast for 2028 projects an adjusted net profit of 954 million yuan [4][5]. - The current stock price corresponds to a P/E ratio of 41 for 2026, 34 for 2027, and 28 for 2028, suggesting a valuation that reflects anticipated recovery in demand for mid to high-end liquor [4][5].

Investment Rating - The investment rating for WuXi Biologics (02269.HK) is "Buy" (maintained) [4][13] Core Insights - In 2025, the company achieved a revenue of 21.79 billion yuan, representing a year-on-year growth of 16.7%. The net profit attributable to shareholders was 4.91 billion yuan, with a year-on-year increase of 46.3%. Adjusted net profit reached 6.59 billion yuan, up 22.0% year-on-year. The gross margin improved to 46.0%, an increase of 5.0 percentage points [4] - The company signed a record 209 new projects in 2025, with two-thirds being dual antibodies and antibody-drug conjugates. The total unfulfilled orders reached 23.72 billion USD by the end of 2025, with 4.53 billion USD expected to be completed within three years [4] - The company is expanding its global capacity, with ongoing construction of facilities in North America and Europe, and has seen steady revenue growth in these regions [6] Financial Summary - Revenue projections for 2026-2028 are 25.48 billion yuan, 30.10 billion yuan, and 35.58 billion yuan, respectively, with corresponding net profits of 5.81 billion yuan, 7.35 billion yuan, and 9.19 billion yuan [8] - The earnings per share (EPS) are forecasted to be 1.4 yuan, 1.8 yuan, and 2.2 yuan for 2026, 2027, and 2028, respectively, with the current stock price corresponding to price-to-earnings (P/E) ratios of 20.7, 16.3, and 13.1 times [4][8] - The company’s gross margin is expected to remain stable at 46.0% in 2026, with a gradual increase to 48.0% by 2028 [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [3] Core Views - The company's performance in 2025 met expectations, and there is anticipation for a recovery in 2026 [3] - The company achieved total revenue of 5.52 billion RMB in 2025, a slight decrease of 0.37% year-on-year, with a net profit of 1.91 billion RMB, down 7.15% year-on-year [6] - The company is focusing on product iteration and expanding its product matrix, particularly in the medical beauty sector, which is expected to drive long-term growth [6] - The company has established a strong market position in the medical device sector and is expanding its product offerings to include various skincare solutions [6] Financial Summary - Revenue projections for 2026 are estimated at 6.07 billion RMB, with a year-on-year growth rate of 9.9% [4] - The projected net profit for 2026 is 1.98 billion RMB, reflecting a growth of 3.4% year-on-year [4] - The company's gross margin is expected to remain strong at approximately 79.3% in 2026 [7] - The company maintains a low debt-to-equity ratio of 8.45%, indicating strong financial health [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a significant increase in underwriting profit, which doubled, and maintained a stable dividend payout ratio [1] - The total revenue for 2025 is projected to be 550.93 billion yuan, with a year-on-year growth of 6.03% [1] - The net profit attributable to shareholders is expected to reach 40.37 billion yuan in 2025, reflecting a year-on-year increase of 25.48% [1] - The book value per share (BVPS) is projected to be 12.86 yuan, with a price-to-book (P/B) ratio of 1.03 at the current price [1] Financial Performance Summary - Total revenue (in million yuan) for 2024A is 519,570, with a projected increase to 550,926 in 2025A [1] - Net profit attributable to shareholders (in million yuan) is forecasted to grow from 32,173 in 2024A to 40,370 in 2025A [1] - The company’s comprehensive cost ratio improved to 97.5% in 2025, a decrease of 1.3 percentage points year-on-year [7] - The total investment income increased by 12.8% year-on-year, with an investment return rate of 5.8% [7][19] Business Segment Performance - The total premium income for property insurance is projected to be 555.8 billion yuan in 2025, with a year-on-year growth of 3.3% [7] - The non-auto insurance premium grew by 3.9%, with health insurance showing the fastest growth at 6.4% [7] - The auto insurance segment saw a premium increase of 2.8%, with a notable growth in new energy vehicle insurance premiums by 31.9% [7] Investment Strategy - The company has increased its allocation to bonds and equity investments, leading to a significant rise in total investment returns [7][19] - The asset allocation includes 57.6% in fixed income and 25.9% in equity, with a notable increase in the proportion of government bonds [7][19]

Investment Rating - The report maintains a "Buy" rating for Anta Sports [1] Core Insights - Anta Sports reported a revenue of RMB 802.2 billion for FY2025, representing a year-on-year growth of 13.3%. The net profit attributable to shareholders was RMB 135.9 billion, with a comparable growth of 13.9% after excluding one-time gains from the Amer Sports listing in FY2024. The company proposed a final dividend of HKD 1.08 per share, resulting in a payout ratio of 50.1% of adjusted net profit, indicating stable shareholder returns [6][9][14] - The main brand, Anta, showed steady growth with a revenue of RMB 347.5 billion, up 3.7% year-on-year, driven by optimized offline channels and improved online operations. FILA brand revenue reached RMB 284.7 billion, growing 6.9%, supported by continuous product upgrades and e-commerce growth. Other brands saw significant growth, with revenue increasing by 59.2% to RMB 170.0 billion [6][9][14] - The company's gross margin slightly decreased by 0.2 percentage points to 62.0%, primarily due to increased investment in product functionality and the rapid growth of lower-margin e-commerce channels. However, the operating profit margin improved by 0.4 percentage points to 23.8% due to effective cost control and operational efficiency [6][14] Financial Data and Profit Forecast - For FY2026, the projected revenue is RMB 893.8 billion, with a year-on-year growth rate of 11%. The net profit attributable to shareholders is expected to be RMB 156.0 billion, reflecting a 15% increase compared to FY2025. The earnings per share (EPS) is forecasted at RMB 5.43 [5][17] - The company’s financial performance indicates a stable operating cash flow of RMB 209.96 billion, a 25.4% increase year-on-year, and free cash flow of RMB 161.06 billion, up 21.5% [6][17]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][18] Core Insights - The company reported a revenue of 19.83 billion RMB in 2025, a decrease of 7.21% year-on-year, while the net profit attributable to shareholders increased by 9.21% to 1.83 billion RMB, which was below expectations [8] - The increase in electricity generation effectively offset the impact of declining electricity prices, with total electricity generation reaching 15.21 billion kWh, a year-on-year increase of 7.71% [8] - The company’s average on-grid electricity price decreased by 0.02 RMB/kWh to 0.41 RMB/kWh in 2025, leading to a mixed performance in the renewable energy sector [8] - The company plans to distribute a cash dividend of 0.20 RMB per share, maintaining a high dividend payout ratio of 49.42%, resulting in a dividend yield of 5.5% based on the closing price [8] - The forecast for net profit attributable to shareholders for 2026 and 2027 has been adjusted downwards to 2.38 billion RMB and 2.73 billion RMB, respectively, with a new estimate for 2028 at 2.91 billion RMB [8] Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2024: 19.83 billion RMB - 2025: 20.72 billion RMB - 2026: 23.34 billion RMB - 2027: 25.66 billion RMB [5] - Net profit attributable to shareholders is projected to be: - 2024: 1.83 billion RMB - 2025: 2.38 billion RMB - 2026: 2.73 billion RMB - 2027: 2.91 billion RMB [5] - The company’s earnings per share (EPS) is expected to grow from 0.40 RMB in 2025 to 0.65 RMB in 2028 [5]

Investment Rating - The report maintains a "Buy" rating for the company [1][2]. Core Insights - The company has shown strong revenue and profit growth over the past 25 years, with a steady recovery in packaged water and robust momentum in tea beverages, leading to the continued "Buy" rating [2]. Financial Summary - Total revenue projections are as follows: - 2024A: 42,896 million - 2025A: 52,553 million (YOY +22.5%) - 2026E: 61,133 million (YOY +16.3%) - 2027E: 70,117 million (YOY +14.7%) - 2028E: 79,391 million (YOY +13.2%) [4] - Gross profit and net profit forecasts are: - Gross profit for 2025A: 31,808 million - Net profit for 2025A: 15,868 million (YOY +30.9%) [4] - The company’s PE ratio is projected to decrease from 35.83 in 2024A to 17.99 in 2028E, indicating improving valuation [4]. Revenue Breakdown - Packaged water sales for 2025 are expected to reach 18,710 million (YOY +17.3%), with a profit margin increase of 6.26 percentage points [10]. - Tea beverage revenue is projected at 21,596 million (YOY +29.0%), with a profit margin increase of 2.87 percentage points [10]. - Functional beverages are expected to generate 5,762 million (YOY +16.8%), while juice sales are projected at 5,176 million (YOY +26.7%) [10]. Market Position - The company maintains a strong market leadership in packaged water, with ongoing efforts to enhance its market share through various channel developments [10]. - The tea beverage segment continues to attract new consumer groups through innovative flavors and packaging [10].

Investment Rating - The report assigns a "Buy" rating for the company, indicating an expected relative performance increase of over 15% against the benchmark index within the next 6 to 12 months [17] Core Insights - The company has achieved continuous revenue and gross profit growth, successfully controlling expenses, and has reported its first quarterly profit [4] - The company is expected to enter a strong new product cycle in 2026, with significant sales growth anticipated due to the launch of multiple new models [8][12] - The company has reached a turning point in profitability, having recorded a positive net profit of 1.2 billion yuan in Q4 2025, marking its first quarterly profit [5] Financial Performance Summary - Revenue projections for the company are as follows: 65,732 million yuan in 2024, 87,488 million yuan in 2025, 132,480 million yuan in 2026, 157,819 million yuan in 2027, and 180,831 million yuan in 2028, with growth rates of 18%, 33%, 51%, 19%, and 15% respectively [3] - The company is expected to achieve a net profit of 99 million yuan in 2026, with significant growth projected in subsequent years, reaching 5,799 million yuan in 2027 and 8,334 million yuan in 2028 [3] - The gross margin is projected to improve to 18.5% in 2026, 19.2% in 2027, and 18.7% in 2028, reflecting ongoing improvements in product mix and operational efficiency [10][12] Sales and Delivery Insights - The company delivered 125,000 vehicles in Q4 2025, representing a year-over-year increase of 71.7% and a quarter-over-quarter increase of 43.3% [7] - The company expects to deliver between 80,000 to 83,000 vehicles in Q1 2026, which would represent a year-over-year growth of 90.1% to 97.2% [7] - The new models launched in 2025, including the Firefly, NIO ES8, and Lido L90, have shown strong market performance, contributing to the anticipated sales growth [6][7]

Investment Rating - The investment rating for Anta Sports is maintained at "Buy" [1] Core Insights - Anta Sports demonstrates resilient performance with a projected revenue of 80.219 billion yuan for 2025, reflecting a year-on-year increase of 13.3%. However, the net profit is expected to decline by 12.9% to 13.588 billion yuan, resulting in a net profit margin of 16.9% and a gross margin of 62.0% [1] - The company's growth momentum is robust in the medium to long term, driven by the main brand benefiting from the Paris Olympic Games, strategic restructuring of FILA, and continued high growth of premium brands like Descente and Kolon [1][2] - The domestic market share remains strong while international expansion accelerates, supported by global collaboration with Amer Sports and market consolidation [1] Financial Summary - For 2025, Anta Sports is expected to achieve total revenue of 80.219 billion yuan, with a year-on-year growth of 13.3%. The net profit is projected at 13.588 billion yuan, down 12.9% from the previous year, with a gross margin of 62.0% and a net profit margin of 16.9% [5] - The earnings per share (EPS) for 2026 is estimated at 5.3 yuan, with a price-to-earnings (P/E) ratio of 12.6 for 2026, decreasing to 10.4 by 2028 [5] Brand Performance - The Anta brand achieved revenue of 34.754 billion yuan in 2025, a 3.7% increase, with an operating profit margin of 20.7% and a gross margin of 53.6% [2] - FILA reported a revenue of 28.469 billion yuan, growing by 6.9%, with an operating profit margin of 26.1%, indicating successful strategic restructuring [3] - Other brands collectively generated revenue of 16.996 billion yuan, a significant increase of 59.2%, becoming a core growth engine for the group [4]